| 摘要 |
<p>The invention concerns combinations of proton pump inhibitors and CCK-B/gastrin antagonists in pharmaceutical compositions that are useful in the treatment of peptic disorders such as ulcers and gastroesophageal reflux disease and in the treatment of Zollinger-Ellison Syndrome.</p> |
